Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Karen Marie Cichowski, Ph.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U01CA202943 (CICHOWSKI, KAREN M) Jun 1, 2016 - May 31, 2021
    Developing a translational pipeline for NF1-mutant malignancies
    Role: Principal Investigator
  2. R01CA198097 (CICHOWSKI, KAREN M) Apr 1, 2016 - Mar 31, 2021
    Co-targeting oncogenic pathways in advanced prostate cancer
    Role: Principal Investigator
  3. R01CA188659 (CICHOWSKI, KAREN M) Sep 18, 2014 - Mar 31, 2020
    Elucidating the role of new RasGAP tumor suppressors in cancer
    Role: Principal Investigator
  4. R13CA177059 (CICHOWSKI, KAREN M) Jun 6, 2013 - May 31, 2014
    FASEB SRC on Regulation and Function of Small GTPases
    Role: Principal Investigator
  5. R01CA129814 (CICHOWSKI, KAREN M) Jul 1, 2007 - Apr 30, 2013
    Elucidating the role of the mTOR pathway in NF1-related tumorigenesis
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Zhang Y, Guillermier C, De Raedt T, Cox AG, Maertens O, Yimlamai D, Lun M, Whitney A, Maas RL, Goessling W, Cichowski K, Steinhauser ML. Imaging Mass Spectrometry Reveals Tumor Metabolic Heterogeneity. iScience. 2020 Aug 21; 23(8):101355. PMID: 32712466.
    Citations: 4     
  2. Guerra SL, Maertens O, Kuzmickas R, De Raedt T, Adeyemi RO, Guild CJ, Guillemette S, Redig AJ, Chambers ES, Xu M, Tiv H, Santagata S, Jänne PA, Elledge SJ, Cichowski K. A Deregulated HOX Gene Axis Confers an Epigenetic Vulnerability in KRAS-Mutant Lung Cancers. Cancer Cell. 2020 05 11; 37(5):705-719.e6. PMID: 32243838.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  3. Tian T, Lofftus S, Pan Y, Stingley CA, King SL, Zhao J, Pan TY, Lock R, Marglous JW, Liu K, Widlund HR, Fuhlbrigge RC, Cichowski K, Kupper TS. IL1a Antagonizes IL1ß and Promotes Adaptive Immune Rejection of Malignant Tumors. Cancer Immunol Res. 2020 05; 8(5):660-671. PMID: 32161110.
    Citations: 6     Fields:    Translation:AnimalsCells
  4. Kim A, Lu Y, Okuno SH, Reinke D, Maertens O, Perentesis J, Basu M, Wolters PL, De Raedt T, Chawla S, Chugh R, Van Tine BA, O'Sullivan G, Chen A, Cichowski K, Widemann BC. Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023). Sarcoma. 2020; 2020:5784876. PMID: 32089640; PMCID: PMC7013290.
    Citations: 14     
  5. Nissim S, Leshchiner I, Mancias JD, Greenblatt MB, Maertens O, Cassa CA, Rosenfeld JA, Cox AG, Hedgepeth J, Wucherpfennig JI, Kim AJ, Henderson JE, Gonyo P, Brandt A, Lorimer E, Unger B, Prokop JW, Heidel JR, Wang XX, Ukaegbu CI, Jennings BC, Paulo JA, Gableske S, Fierke CA, Getz G, Sunyaev SR, Wade Harper J, Cichowski K, Kimmelman AC, Houvras Y, Syngal S, Williams C, Goessling W. Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer. Nat Genet. 2019 09; 51(9):1308-1314. PMID: 31406347; PMCID: PMC7159804.
    Citations: 22     Fields:    Translation:HumansAnimalsCells
  6. Widemann BC, Lu Y, Reinke D, Okuno SH, Meyer CF, Cote GM, Chugh R, Milhem MM, Hirbe AC, Kim A, Turpin B, Pressey JG, Dombi E, Jayaprakash N, Helman LJ, Onwudiwe N, Cichowski K, Perentesis JP. Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016). Sarcoma. 2019; 2019:7656747. PMID: 31427883; PMCID: PMC6681622.
    Citations: 20     
  7. Haigis KM, Cichowski K, Elledge SJ. Tissue-specificity in cancer: The rule, not the exception. Science. 2019 Mar 15; 363(6432):1150-1151. PMID: 30872507.
    Citations: 60     Fields:    Translation:Humans
  8. Maertens O, Kuzmickas R, Manchester HE, Emerson CE, Gavin AG, Guild CJ, Wong TC, De Raedt T, Bowman-Colin C, Hatchi E, Garraway LA, Flaherty KT, Pathania S, Elledge SJ, Cichowski K. MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in BRAF-, NRAS-, and NF1-Mutant Melanomas. Cancer Discov. 2019 04; 9(4):526-545. PMID: 30709805.
    Citations: 27     Fields:    Translation:HumansCells
  9. Liao S, Maertens O, Cichowski K, Elledge SJ. Genetic modifiers of the BRD4-NUT dependency of NUT midline carcinoma uncovers a synergism between BETis and CDK4/6is. Genes Dev. 2018 09 01; 32(17-18):1188-1200. PMID: 30135075; PMCID: PMC6120715.
    Citations: 22     Fields:    Translation:HumansAnimalsCells
  10. Takahashi N, Chen HY, Harris IS, Stover DG, Selfors LM, Bronson RT, Deraedt T, Cichowski K, Welm AL, Mori Y, Mills GB, Brugge JS. Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance. Cancer Cell. 2018 06 11; 33(6):985-1003.e7. PMID: 29805077; PMCID: PMC6100788.
    Citations: 72     Fields:    Translation:HumansAnimalsCells
  11. Singleton KR, Crawford L, Tsui E, Manchester HE, Maertens O, Liu X, Liberti MV, Magpusao AN, Stein EM, Tingley JP, Frederick DT, Boland GM, Flaherty KT, McCall SJ, Krepler C, Sproesser K, Herlyn M, Adams DJ, Locasale JW, Cichowski K, Mukherjee S, Wood KC. Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence. Cell Rep. 2017 Dec 05; 21(10):2796-2812. PMID: 29212027; PMCID: PMC5728698.
    Citations: 32     Fields:    Translation:HumansCells
  12. Maertens O, McCurrach ME, Braun BS, De Raedt T, Epstein I, Huang TQ, Lauchle JO, Lee H, Wu J, Cripe TP, Clapp DW, Ratner N, Shannon K, Cichowski K. A Collaborative Model for Accelerating the Discovery and Translation of Cancer Therapies. Cancer Res. 2017 11 01; 77(21):5706-5711. PMID: 28993414; PMCID: PMC5668167.
    Citations: 11     Fields:    Translation:HumansAnimals
  13. Malone CF, Emerson C, Ingraham R, Barbosa W, Guerra S, Yoon H, Liu LL, Michor F, Haigis M, Macleod KF, Maertens O, Cichowski K. mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven Tumors. Cancer Discov. 2017 12; 7(12):1450-1463. PMID: 28963352; PMCID: PMC5718976.
    Citations: 43     Fields:    Translation:HumansCells
  14. Olsen SN, Wronski A, Castaño Z, Dake B, Malone C, De Raedt T, Enos M, DeRose YS, Zhou W, Guerra S, Loda M, Welm A, Partridge AH, McAllister SS, Kuperwasser C, Cichowski K. Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers. Cancer Discov. 2017 02; 7(2):202-217. PMID: 27974415; PMCID: PMC6461361.
    Citations: 32     Fields:    Translation:HumansAnimalsCells
  15. Zhang H, Qi J, Reyes JM, Li L, Rao PK, Li F, Lin CY, Perry JA, Lawlor MA, Federation A, De Raedt T, Li YY, Liu Y, Duarte MA, Zhang Y, Herter-Sprie GS, Kikuchi E, Carretero J, Perou CM, Reibel JB, Paulk J, Bronson RT, Watanabe H, Brainson CF, Kim CF, Hammerman PS, Brown M, Cichowski K, Long H, Bradner JE, Wong KK. Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer. Cancer Discov. 2016 09; 6(9):1006-21. PMID: 27312177.
    Citations: 41     Fields:    Translation:HumansAnimalsCells
  16. Lock R, Ingraham R, Maertens O, Miller AL, Weledji N, Legius E, Konicek BM, Yan SC, Graff JR, Cichowski K. Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers. J Clin Invest. 2016 06 01; 126(6):2181-90. PMID: 27159396; PMCID: PMC4887164.
    Citations: 19     Fields:    Translation:HumansAnimalsCells
  17. Lock R, Cichowski K. Loss of negative regulators amplifies RAS signaling. Nat Genet. 2015 May; 47(5):426-7. PMID: 25916896.
    Citations: 2     Fields:    Translation:Animals
  18. Montero J, Sarosiek KA, DeAngelo JD, Maertens O, Ryan J, Ercan D, Piao H, Horowitz NS, Berkowitz RS, Matulonis U, Jänne PA, Amrein PC, Cichowski K, Drapkin R, Letai A. Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy. Cell. 2015 Feb 26; 160(5):977-989. PMID: 25723171.
    Citations: 164     Fields:    Translation:HumansCells
  19. De Raedt T, Beert E, Pasmant E, Luscan A, Brems H, Ortonne N, Helin K, Hornick JL, Mautner V, Kehrer-Sawatzki H, Clapp W, Bradner J, Vidaud M, Upadhyaya M, Legius E, Cichowski K. PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies. Nature. 2014 Oct 09; 514(7521):247-51. PMID: 25119042.
    Citations: 210     Fields:    Translation:HumansAnimalsCells
  20. Malone CF, Fromm JA, Maertens O, DeRaedt T, Ingraham R, Cichowski K. Defining key signaling nodes and therapeutic biomarkers in NF1-mutant cancers. Cancer Discov. 2014 Sep; 4(9):1062-73. PMID: 24913553; PMCID: PMC4446704.
    Citations: 33     Fields:    Translation:HumansCells
  21. Maertens O, Cichowski K. Paths of resistance to EGFR inhibitors: is NF enough? Cancer Discov. 2014 May; 4(5):519-21. PMID: 24795011.
    Citations: 2     Fields:    Translation:Humans
  22. Maertens O, Cichowski K. An expanding role for RAS GTPase activating proteins (RAS GAPs) in cancer. Adv Biol Regul. 2014 May; 55:1-14. PMID: 24814062.
    Citations: 77     Fields:    Translation:Humans
  23. Widemann BC, Acosta MT, Ammoun S, Belzberg AJ, Bernards A, Blakeley J, Bretscher A, Cichowski K, Clapp DW, Dombi E, Evans GD, Ferner R, Fernandez-Valle C, Fisher MJ, Giovannini M, Gutmann DH, Hanemann CO, Hennigan R, Huson S, Ingram D, Kissil J, Korf BR, Legius E, Packer RJ, McClatchey AI, McCormick F, North K, Pehrsson M, Plotkin SR, Ramesh V, Ratner N, Schirmer S, Sherman L, Schorry E, Stevenson D, Stewart DR, Ullrich N, Bakker AC, Morrison H. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. Am J Med Genet A. 2014 Mar; 164A(3):563-78. PMID: 24443315.
    Citations: 8     Fields:    Translation:Humans
  24. McLaughlin SK, Olsen SN, Dake B, De Raedt T, Lim E, Bronson RT, Beroukhim R, Polyak K, Brown M, Kuperwasser C, Cichowski K. The RasGAP gene, RASAL2, is a tumor and metastasis suppressor. Cancer Cell. 2013 Sep 09; 24(3):365-78. PMID: 24029233.
    Citations: 70     Fields:    Translation:HumansAnimalsCells
  25. Hollstein PE, Cichowski K. Identifying the Ubiquitin Ligase complex that regulates the NF1 tumor suppressor and Ras. Cancer Discov. 2013 Aug; 3(8):880-93. PMID: 23661552.
    Citations: 27     Fields:    Translation:HumansAnimalsCells
  26. Maertens O, Johnson B, Hollstein P, Frederick DT, Cooper ZA, Messiaen L, Bronson RT, McMahon M, Granter S, Flaherty K, Wargo JA, Marais R, Cichowski K. Elucidating distinct roles for NF1 in melanomagenesis. Cancer Discov. 2013 Mar; 3(3):338-49. PMID: 23171796.
    Citations: 107     Fields:    Translation:HumansAnimalsCells
  27. McClatchey AI, Cichowski K. SPRED proteins provide a NF-ty link to Ras suppression. Genes Dev. 2012 Jul 15; 26(14):1515-9. PMID: 22802525.
    Citations: 8     Fields:    Translation:HumansAnimals
  28. Kalamarides M, Acosta MT, Babovic-Vuksanovic D, Carpen O, Cichowski K, Evans DG, Giancotti F, Hanemann CO, Ingram D, Lloyd AC, Mayes DA, Messiaen L, Morrison H, North K, Packer R, Pan D, Stemmer-Rachamimov A, Upadhyaya M, Viskochil D, Wallace MR, Hunter-Schaedle K, Ratner N. Neurofibromatosis 2011: a report of the Children's Tumor Foundation annual meeting. Acta Neuropathol. 2012 Mar; 123(3):369-80. PMID: 22083253.
    Citations: 10     Fields:    Translation:Humans
  29. De Raedt T, Walton Z, Yecies JL, Li D, Chen Y, Malone CF, Maertens O, Jeong SM, Bronson RT, Lebleu V, Kalluri R, Normant E, Haigis MC, Manning BD, Wong KK, Macleod KF, Cichowski K. Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell. 2011 Sep 13; 20(3):400-13. PMID: 21907929.
    Citations: 130     Fields:    Translation:AnimalsCells
  30. Beert E, Brems H, Daniëls B, De Wever I, Van Calenbergh F, Schoenaers J, Debiec-Rychter M, Gevaert O, De Raedt T, Van Den Bruel A, de Ravel T, Cichowski K, Kluwe L, Mautner V, Sciot R, Legius E. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors. Genes Chromosomes Cancer. 2011 Dec; 50(12):1021-32. PMID: 21987445.
    Citations: 89     Fields:    Translation:HumansCells
  31. Huson SM, Acosta MT, Belzberg AJ, Bernards A, Chernoff J, Cichowski K, Gareth Evans D, Ferner RE, Giovannini M, Korf BR, Listernick R, North KN, Packer RJ, Parada LF, Peltonen J, Ramesh V, Reilly KM, Risner JW, Schorry EK, Upadhyaya M, Viskochil DH, Zhu Y, Hunter-Schaedle K, Giancotti FG. Back to the future: proceedings from the 2010 NF Conference. Am J Med Genet A. 2011 Feb; 155A(2):307-21. PMID: 21271647.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  32. Cichowski K, Jänne PA. Drug discovery: inhibitors that activate. Nature. 2010 Mar 18; 464(7287):358-9. PMID: 20237552.
    Citations: 34     Fields:    Translation:HumansAnimalsCells
  33. Min J, Zaslavsky A, Fedele G, McLaughlin SK, Reczek EE, De Raedt T, Guney I, Strochlic DE, Macconaill LE, Beroukhim R, Bronson RT, Ryeom S, Hahn WC, Loda M, Cichowski K. An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB. Nat Med. 2010 Mar; 16(3):286-94. PMID: 20154697.
    Citations: 203     Fields:    Translation:HumansAnimalsCells
  34. McGillicuddy LT, Fromm JA, Hollstein PE, Kubek S, Beroukhim R, De Raedt T, Johnson BW, Williams SM, Nghiemphu P, Liau LM, Cloughesy TF, Mischel PS, Parret A, Seiler J, Moldenhauer G, Scheffzek K, Stemmer-Rachamimov AO, Sawyers CL, Brennan C, Messiaen L, Mellinghoff IK, Cichowski K. Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis. Cancer Cell. 2009 Jul 07; 16(1):44-54. PMID: 19573811.
    Citations: 80     Fields:    Translation:AnimalsCells
  35. Cichowski K, Hahn WC. Unexpected pieces to the senescence puzzle. Cell. 2008 Jun 13; 133(6):958-61. PMID: 18555773.
    Citations: 27     Fields:    Translation:HumansAnimals
  36. Courtois-Cox S, Jones SL, Cichowski K. Many roads lead to oncogene-induced senescence. Oncogene. 2008 May 01; 27(20):2801-9. PMID: 18193093.
    Citations: 185     Fields:    Translation:HumansAnimals
  37. Johannessen CM, Johnson BW, Williams SM, Chan AW, Reczek EE, Lynch RC, Rioth MJ, McClatchey A, Ryeom S, Cichowski K. TORC1 is essential for NF1-associated malignancies. Curr Biol. 2008 Jan 08; 18(1):56-62. PMID: 18164202.
    Citations: 102     Fields:    Translation:AnimalsCells
  38. Courtois-Cox S, Genther Williams SM, Reczek EE, Johnson BW, McGillicuddy LT, Johannessen CM, Hollstein PE, MacCollin M, Cichowski K. A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell. 2006 Dec; 10(6):459-72. PMID: 17157787; PMCID: PMC2692661.
    Citations: 251     Fields:    Translation:HumansAnimalsCells
  39. Johannessen CM, Reczek EE, James MF, Brems H, Legius E, Cichowski K. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci U S A. 2005 Jun 14; 102(24):8573-8. PMID: 15937108; PMCID: PMC1142482.
    Citations: 235     Fields:    Translation:AnimalsCells
  40. Engelman JA, Jänne PA, Mermel C, Pearlberg J, Mukohara T, Fleet C, Cichowski K, Johnson BE, Cantley LC. ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines. Proc Natl Acad Sci U S A. 2005 Mar 08; 102(10):3788-93. PMID: 15731348; PMCID: PMC553328.
    Citations: 189     Fields:    Translation:HumansAnimalsCells
  41. Stemmer-Rachamimov AO, Louis DN, Nielsen GP, Antonescu CR, Borowsky AD, Bronson RT, Burns DK, Cervera P, McLaughlin ME, Reifenberger G, Schmale MC, MacCollin M, Chao RC, Cichowski K, Kalamarides M, Messerli SM, McClatchey AI, Niwa-Kawakita M, Ratner N, Reilly KM, Zhu Y, Giovannini M. Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Res. 2004 May 15; 64(10):3718-24. PMID: 15150133.
    Citations: 41     Fields:    Translation:HumansAnimals
  42. Cichowski K, Santiago S, Jardim M, Johnson BW, Jacks T. Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor. Genes Dev. 2003 Feb 15; 17(4):449-54. PMID: 12600938; PMCID: PMC195996.
    Citations: 58     Fields:    Translation:AnimalsCells
  43. Cichowski K, Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell. 2001 Feb 23; 104(4):593-604. PMID: 11239415.
    Citations: 240     Fields:    Translation:HumansAnimalsCells
  44. McClatchey AI, Cichowski K. Mouse models of neurofibromatosis. Biochim Biophys Acta. 2001; 1471(2):M73-80. PMID: 11342186.
    Citations: 2     Fields:    Translation:HumansAnimals
  45. Cichowski K, Shih TS, Schmitt E, Santiago S, Reilly K, McLaughlin ME, Bronson RT, Jacks T. Mouse models of tumor development in neurofibromatosis type 1. Science. 1999 Dec 10; 286(5447):2172-6. PMID: 10591652.
    Citations: 173     Fields:    Translation:HumansAnimalsCells
  46. Halper AS, Cherney LR, Cichowski K, Zhang M. Dysphagia after head trauma: the effect of cognitive-communicative impairments on functional outcomes. J Head Trauma Rehabil. 1999 Oct; 14(5):486-96. PMID: 10653944.
    Citations: 10     Fields:    Translation:Humans
  47. Cichowski K, Orsini MJ, Brass LF. PAR1 activation initiates integrin engagement and outside-in signalling in megakaryoblastic CHRF-288 cells. Biochim Biophys Acta. 1999 Jul 08; 1450(3):265-76. PMID: 10395938.
    Citations: 3     Fields:    Translation:HumansCells
  48. Johnson L, Greenbaum D, Cichowski K, Mercer K, Murphy E, Schmitt E, Bronson RT, Umanoff H, Edelmann W, Kucherlapati R, Jacks T. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 1997 Oct 01; 11(19):2468-81. PMID: 9334313; PMCID: PMC316567.
    Citations: 181     Fields:    Translation:AnimalsCells
  49. Brass LF, Manning DR, Cichowski K, Abrams CS. Signaling through G proteins in platelets: to the integrins and beyond. Thromb Haemost. 1997 Jul; 78(1):581-9. PMID: 9198220.
    Citations: 30     Fields:    Translation:HumansCells
  50. Cichowski K, Shih TS, Jacks T. Nf1 gene targeting: toward models and mechanisms. Semin Cancer Biol. 1996 Oct; 7(5):291-8. PMID: 9110406.
    Citations: 5     Fields:    Translation:HumansAnimals
  51. Cichowski K, Brugge JS, Brass LF. Thrombin receptor activation and integrin engagement stimulate tyrosine phosphorylation of the proto-oncogene product, p95vav, in platelets. J Biol Chem. 1996 Mar 29; 271(13):7544-50. PMID: 8631786.
    Citations: 20     Fields:    Translation:HumansCells
  52. Brass LF, Vassallo RR, Belmonte E, Ahuja M, Cichowski K, Hoxie JA. Structure and function of the human platelet thrombin receptor. Studies using monoclonal antibodies directed against a defined domain within the receptor N terminus. J Biol Chem. 1992 Jul 15; 267(20):13795-8. PMID: 1321125.
    Citations: 26     Fields:    Translation:HumansAnimalsCells
  53. Vassallo RR, Kieber-Emmons T, Cichowski K, Brass LF. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J Biol Chem. 1992 Mar 25; 267(9):6081-5. PMID: 1313429.
    Citations: 52     Fields:    Translation:HumansAnimalsCells
  54. Cichowski K, McCormick F, Brugge JS. p21rasGAP association with Fyn, Lyn, and Yes in thrombin-activated platelets. J Biol Chem. 1992 Mar 15; 267(8):5025-8. PMID: 1544885.
    Citations: 18     Fields:    Translation:HumansCells
  55. Corvera S, Bartels JL, Capocasale RJ, Cichowski K, Moore JS. Increased assembly of clathrin occurs in response to mitogenic activation of murine lymphocytes. J Biol Chem. 1989 Jul 25; 264(21):12568-72. PMID: 2663860.
    Citations: 1     Fields:    Translation:AnimalsCells
  56. Heinemann AW, Roth EJ, Cichowski K, Betts HB. Multivariate analysis of improvement and outcome following stroke rehabilitation. Arch Neurol. 1987 Nov; 44(11):1167-72. PMID: 3675249.
    Citations: 16     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Cichowski's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (331)
Co-Authors (60)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.